Xeomin has been used in clinical practice for more than 10 years, with over 127,000 people having received injections of this drug, and to date, not a single patient has been identified who failed to show a secondary clinical response.
An in-depth analysis of the lack of effect of botulinum toxin type A treatment and the decline in its efficacy with long-term use. Causes of nonresponse or reduced effect with prolonged administration.
Modern aesthetic medicine offers two identical products for eliminating expression lines — Botox and Dysport. But how do they differ? And which one should you choose?
About the project
EstPortal.com (Aesthetic Portal) – is a professional resource dedicated to beauty. The project will be of interest to both beauty industry specialists and its connoisseurs. The aim of the project: to provide maximum time saving on search of necessary information for beauty industry specialists and site visitors.